Cocrystal Pharma, Inc. — Director's Dealing 2023

Jul 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2023-07-18

Reporting Person: FROST PHILLIP MD ET AL (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-18	Stock Options (Right to Buy)	$2.67	A	19333	Acquired	2033-07-18	Common Stock (19333)	Direct

Footnotes

F1: The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.